Literature DB >> 12963375

Alternative splicing as a mechanism for regulating 14-3-3 binding: interactions between hD53 (TPD52L1) and 14-3-3 proteins.

Rose Boutros1, Angela M Bailey, Sarah H D Wilson, Jennifer A Byrne.   

Abstract

D52 (TPD52)-like proteins are coiled-coil motif-bearing proteins first identified through their expression in human breast carcinoma, which have been proposed to represent signalling intermediates and regulators of vesicle trafficking. D52-like gene transcripts are subject to alternative splicing, with sequences encoding a region termed insert 3 being affected in all three D52-like genes. We have now identified a 14-3-3 binding motif within one of two alternatively spliced exons encoding insert 3. As predicted from the distribution of 14-3-3 binding motifs in four hD52-like bait proteins tested, only a hD53 isoform encoding a 14-3-3 binding motif bound both 14-3-3beta and 14-3-3zeta preys in the yeast two-hybrid system. Since D53 proteins carrying 14-3-3 binding motifs are predicted to be widely expressed, polyclonal antisera were derived to specifically detect these isoforms. Using soluble protein extracts from breast carcinoma cell lines, pull-down assays replicated interactions between recombinant 14-3-3beta and 14-3-3zeta isoforms and exogenously expressed hD53, and co-immunoprecipitation analyses demonstrated interactions between endogenous 14-3-3 and both endogenously and exogenously-expressed hD53 protein. Co-expressed hD53 and 14-3-3 proteins were similarly demonstrated to co-localise within the cytoplasm of breast carcinoma cell lines. These results identify 14-3-3 proteins as partners for hD53, and alternative splicing as a mechanism for regulating 14-3-3 binding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963375     DOI: 10.1016/s0022-2836(03)00944-6

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  15 in total

1.  Lentivirus-mediated TPD52L2 depletion inhibits the proliferation of liver cancer cells in vitro.

Authors:  Ze-Ya Pan; Yun Yang; Hao Pan; Jin Zhang; Hui Liu; Yuan Yang; Gang Huang; Lei Yin; Jian Huang; Wei-Ping Zhou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  TPD52 expression increases neutral lipid storage within cultured cells.

Authors:  Alvin Kamili; Nuruliza Roslan; Sarah Frost; Laurence C Cantrill; Dongwei Wang; Austin Della-Franca; Robert K Bright; Guy E Groblewski; Beate K Straub; Andrew J Hoy; Yuyan Chen; Jennifer A Byrne
Journal:  J Cell Sci       Date:  2015-07-16       Impact factor: 5.285

3.  Identification of PLP2 and RAB5C as novel TPD52 binding partners through yeast two-hybrid screening.

Authors:  Hamideh Shahheydari; Sarah Frost; Brian J Smith; Guy E Groblewski; Yuyan Chen; Jennifer A Byrne
Journal:  Mol Biol Rep       Date:  2014-03-07       Impact factor: 2.316

4.  Transcription variants of the prostate-specific PrLZ gene and their interaction with 14-3-3 proteins.

Authors:  Ruoxiang Wang; Hui He; Xiaojuan Sun; Jianchun Xu; Fray F Marshall; Haiyen Zhau; Leland W K Chung; Haian Fu; Dalin He
Journal:  Biochem Biophys Res Commun       Date:  2009-09-02       Impact factor: 3.575

5.  A role for tumor protein TPD52 phosphorylation in endo-membrane trafficking during cytokinesis.

Authors:  Diana D H Thomas; Christina L Frey; Scott W Messenger; Benjamin K August; Guy E Groblewski
Journal:  Biochem Biophys Res Commun       Date:  2010-10-12       Impact factor: 3.575

6.  Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.

Authors:  Yoshiki Mukudai; Seiji Kondo; Atsushi Fujita; Yasuto Yoshihama; Tatsuo Shirota; Satoru Shintani
Journal:  Cell Oncol (Dordr)       Date:  2013-03-26       Impact factor: 6.730

7.  RNA sequencing of MCF-7 breast cancer cells identifies novel estrogen-responsive genes with functional estrogen receptor-binding sites in the vicinity of their transcription start sites.

Authors:  Ryonosuke Yamaga; Kazuhiro Ikeda; Kuniko Horie-Inoue; Yasuyoshi Ouchi; Yutaka Suzuki; Satoshi Inoue
Journal:  Horm Cancer       Date:  2013-03-23       Impact factor: 3.869

8.  Bioinformatic and experimental survey of 14-3-3-binding sites.

Authors:  Catherine Johnson; Sandra Crowther; Margaret J Stafford; David G Campbell; Rachel Toth; Carol MacKintosh
Journal:  Biochem J       Date:  2010-03-15       Impact factor: 3.857

9.  Identification of testis 14-3-3 binding proteins by tandem affinity purification.

Authors:  Pawan Puri; Amparo Acker-Palmer; Ryan Stahler; Yijing Chen; Douglas Kline; Srinivasan Vijayaraghavan
Journal:  Spermatogenesis       Date:  2011-10-01

10.  Tumor protein D52 represents a negative regulator of ATM protein levels.

Authors:  Yuyan Chen; Alvin Kamili; Jayne R Hardy; Guy E Groblewski; Kum Kum Khanna; Jennifer A Byrne
Journal:  Cell Cycle       Date:  2013-08-21       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.